Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06056921RecruitingPhase 1
CAR T-cell therapy for hard-to-treat autoimmune diseases
This trial tests a new treatment using your own immune cells (CAR T-cells) targeting a protein called CD19 to control severe autoimmune diseases like lupus, Sjogren's, scleroderma, dermatomyositis, or vasculitis. The goal is to see if it's safe and can improve symptoms when other treatments haven't worked.
Taiyuan, ShanxiAges 18 years+ - NCT06059469RecruitingPhase 2
PSMA scan for advanced triple-negative breast cancer
This trial uses a special scan (PSMA-PET/CT) to see if your breast cancer makes a protein called PSMA. The results might help guide your future treatment.
BrusselsAges 18 years+ - NCT06059391RecruitingPhase 2
Vaccine for stem cell donors to prevent CMV
This trial tests whether giving a CMV vaccine to stem cell donors can help protect recipients from CMV infection after transplant. It is for adults with specific blood cancers who are CMV-positive and have a matched related donor.
Duarte, CaliforniaAges 18–75 - NCT06059716Recruiting
Gluten detection and education for new celiac diagnosis
This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.
Chicago, IllinoisAges 18–75 - NCT06061042Recruiting
Time-restricted eating for metabolic health
This study tests whether eating only during a specific time window each day can improve metabolic health in people with obesity and insulin resistance. If you have a high BMI and early signs of diabetes, this trial might help you understand a simple dietary change.
Amsterdam, North HollandAges 50–75 - NCT06060782RecruitingPhase 1
Chemo combo for high-risk blood cancer transplant patients
This trial tests a combination of drugs (thiotepa, cyclophosphamide, clarithromycin, and cytarabine) before a stem cell transplant. It is for people with certain types of blood cancer who have responded well to earlier treatment.
Zhuhai, GuangdongAges 18–65 - NCT06061276Recruiting
Combined therapy for large liver cancer with limited spread
This trial tests a combination of treatments—bland transarterial embolization (bTAE), hepatic artery infusion chemotherapy (HAIC), and systemic therapy—for people with large liver cancers that have limited spread. It might be an option if you have a big tumor and your liver is still working well.
Guanzhou, GuangdongAges 18–75 - NCT06061822Recruiting
Testing AI for better heart MRI scans
This trial is testing a new artificial intelligence system that helps doctors take clearer, faster heart images using MRI. It aims to make heart scans more accurate and comfortable for patients.
LondonAges 18 years+ - NCT06062199Recruiting
Study on easier first-attempt IV insertion
This trial tests a new scoring method called A-DIVA to help nurses find a vein on the first try when starting an IV (VVP). It may reduce multiple needle sticks and improve comfort.
Clermont-FerrandAges 18 years+ - NCT06062693Recruiting
Home Hand Training with Sensors for Better Dexterity
This study tests a new home-based hand training system using sensors to help improve hand movement and dexterity in people with Parkinson's, multiple sclerosis, or stroke. It also includes healthy volunteers for comparison.
LucerneAges 18–99 - NCT06063564Recruiting
Testing a digital tool to improve heart health in rural clinics
This study is testing a digital health app called PREVENT to help doctors and patients work together on heart-healthy habits like eating well and being active. It is designed for people in rural areas who want to lower their risk of heart disease.
St Louis, MissouriAges 18–64 - NCT06064695Recruiting
Electrical muscle stimulation exercise for myasthenia gravis
This study tests if whole-body electrical muscle stimulation exercise can help adults with generalized myasthenia gravis. It also enrolls healthy controls for comparison. If you have MG and can stand for about 15 minutes, this may be an option.
Fairway, KansasAges 18 years+ - NCT06064864Recruiting
Switching Infliximab from IV to Subcutaneous for Crohn's
This study tests whether switching from an IV infliximab to a subcutaneous (under-the-skin) version is safe and works well for people with moderate to severe Crohn's disease. It's for people who have never used a biologic and need a new treatment option.
SeoulAges 18–100 - NCT06065982Recruiting
Study of a method for placing a dialysis catheter (PREDICT)
This study watches how well a certain method (percutaneous) works for placing a peritoneal dialysis (PD) catheter, which is a soft tube used for a type of kidney dialysis. By tracking patients’ experiences before and after the procedure, the study aims to improve care for people with kidney failure.
BrusselsAges 18 years+ - NCT06066450Recruiting
OSFIT Stent for Coronary Artery Blockage
This trial tests a special stent (OSFIT) in people with a blockage near the start of a coronary artery. The goal is to see if the stent works well for this specific location.
SuwonAges 19 years+ - NCT06066905Recruiting
Study of chidamide and azacitidine for AML patients with MRD after transplant
This trial tests whether a combination of two drugs, chidamide and azacitidine (AZA), can help people with acute myeloid leukemia (AML) who still have small amounts of leukemia cells (called MRD) after a stem cell transplant. The goal is to see if this treatment can clear those leftover cells and lower the chance of the leukemia coming back.
Guangzhou, GuangdongAges 18 years+ - NCT06066918Recruiting
Preventing pain after spinal cord injury with Pregabalin
This study tests if taking Pregabalin early after a spinal cord injury can prevent pain from developing. It's a drug that may help calm nerve signals.
RaananaAges 18 years+ - NCT06066970Recruiting
Studying heart markers after valve surgery
This trial uses a special MRI and blood tests to see how heart muscle is affected after aortic or mitral valve surgery. It may help doctors better understand and monitor heart recovery.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06067867Recruiting
Kidney and pregnancy registry study
This study tracks the health of women with kidney problems before, during, and after pregnancy to learn how to better care for them. It is for women who have had kidney disease, high blood pressure, certain pregnancy complications, or a kidney transplant.
BrusselsAges 18 years+ - NCT06068322Recruiting
Very intense interval training for people with COPD
This study tests whether a very intense, short burst of exercise (supramaximal high-intensity interval training) is safe and effective for people aged 60 and older with or without COPD. It aims to see if this type of exercise can improve fitness and daily life.
Hasselt, DiepenbeekAges 60 years+ - NCT06068764RecruitingPhase 4
Comparing Two Anesthesia Drugs for Bypass Surgery
This study compares two common anesthesia medicines (etomidate and propofol) for patients having planned coronary artery bypass surgery. The goal is to see which medication works better for your heart and recovery.
Hartford, ConnecticutAges 18–90 - NCT06069115Recruiting
How radiation affects lung function in breast cancer patients
This study looks at how radiation therapy for breast cancer may affect your lungs over time. Researchers will measure lung function and see if problems develop, so they can better understand and protect patients.
Novosibirsk, Novosibirsk OblastAges 18 years+ - NCT06070454Recruiting
Study on infection and wound healing after vulvar surgery
This study looks at whether having an infection before surgery affects healing after removal of non-cancerous vulvar growths. It may help decide if treating infections first could lower complication rates.
Charlottesville, VirginiaAges 18 years+ - NCT06070636Recruiting
Triple therapy for aggressive liver cancer
This trial tests a combination of three treatments for a specific type of aggressive liver cancer called infiltrative hepatocellular carcinoma (HCC). It combines targeted therapy (lenvatinib), immunotherapy (sintilimab), and a procedure that delivers chemotherapy directly to the liver (bTAE-HAIC). The goal is to see if this triple approach works better for people with large tumors or those that have spread to the portal vein.
Guangzhou, GuangdongAges 18–75
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.